|
.
See Category: Diseases of the skin and subcutaneous tissue
ICD-10 (CM) Code and Descriptor
L66.9 |
Cicatricial alopecia, unspecified
|
L669 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
54.98%
|
20.75%
|
9.10%
|
4.43%
|
3.64%
|
2.37%
|
1.58%
|
1.03%
|
0.49%
|
0.18%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L66.9*:
CPT |
Description |
Number of Claims |
Sum Performed |
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
588
|
588
|
J3301
|
TRIAMCINOLONE ACET INJ NOS |
175
|
347
|
11900
|
INJECT SKIN LESIONS |
140
|
140
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
101
|
124
|
11901
|
INJECT SKIN LESIONS >7 |
100
|
100
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
79
|
80
|
11104
|
PUNCH BX SKIN SINGLE LESION |
55
|
55
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
44
|
44
|
80053
|
COMPREHEN METABOLIC PANEL |
32
|
32
|
84443
|
ASSAY THYROID STIM HORMONE |
29
|
29
|
82728
|
ASSAY OF FERRITIN |
29
|
29
|
11105
|
PUNCH BX SKIN EA SEP/ADDL |
29
|
30
|
88312
|
SPECIAL STAINS GROUP 1 |
23
|
31
|
83540
|
ASSAY OF IRON |
21
|
21
|
86038
|
ANTINUCLEAR ANTIBODIES |
19
|
19
|
83550
|
IRON BINDING TEST |
19
|
19
|
Q3014
|
TELEHEALTH FACILITY FEE |
18
|
18
|
82306
|
VITAMIN D 25 HYDROXY |
18
|
18
|
17110
|
DESTRUCT B9 LESION 1-14 |
13
|
13
|
82607
|
VITAMIN B-12 |
11
|
11
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L66.9 related to the following DRG Codes:
606-607
|